Changing mode of economic development of China's pharmaceutical industry will be bright prospect

March 5, Premier Wen Jiabao's government work report to the National People's Congress, in the Speaking of change in mode of development, he stressed that "urgent changes in mode of economic development."
� 
One economist pointed out that since the end of 2009 the Central Economic Work Conference, the Central high-level re-issued the "change" a strong signal, indicating changes in mode of development has been referred to an unprecedented height, "change" will be the policy direction in 2010 Key words.
� 
"Relative to capital, technology, personnel, products, the impact of the pharmaceutical industry or the most fundamental factor for the development of policy." China Pharmaceutical Enterprise Management Association, the former State Economic and Trade Commission Medical Secretary Ming believes that China's economic development mode from the pure pursuit of GDP growth, changing to a more focus on improving the quality and efficiency of economic growth, more emphasis on environmental protection, energy conservation and people's livelihood. In this process, the pharmaceutical industry is also promising responsibility. "Our country from the 'Pharmaceutical big country' to 'pharmaceutical powers' change, the pharmaceutical industry, an urgent need to change mode of economic development."
� 
1, change without delay
� 
China Chemical Pharmaceutical Industry Association senior expert Yu Guan-wen said that the new China was founded 60 years ago, China's pharmaceutical industry has made remarkable achievements. Weak base from the pharmaceutical industry started to develop into research, education, design, production, market development combined production of raw materials, intermediates, formulations, pharmaceutical excipients, pharmaceutical package materials, pharmaceutical equipment, industrial system that complements, for the people prevent and cure diseases, rehabilitation, health care, improve health and make a positive contribution to, and received great development.
� 
Relevant statistical data show that in 1978 total output value of China's pharmaceutical industry is 7.281 billion yuan, in 2008 total output value of the pharmaceutical industry rose to 866.62 billion yuan, an increase of 119 times. Last year, the global financial crisis and economic downturn, the pharmaceutical industry output value is a breakthrough trillion yuan mark, reaching 1.044 trillion yuan, an increase of 21.18%. "Over the last eight years, China's pharmaceutical industry compound average growth rate of 20.45%, higher than the growth rate of 12 percent global pharmaceutical." China Chemical Pharmaceutical Industry Association, vice president of Pan Guangcheng have been very proud of. China Nonprescription Medicines Association, the former State Food and Drug Administration Work Safety Secretary Bai Hui Liang said the reform and opening up 30 years ago, China's pharmaceutical industry output growth is the level of growth over the same period the United States and Japan, 12.7 times the level of growth of the six-fold, China chemical raw materials has become the world's No. 1 producer.
� 
But in our medicine's rapid economic growth, the industry's own problems let regulators and experts with good reason.
� 
"Rapid development of the pharmaceutical industry contains some of the extensive problems arising from operating in more and more obvious development of the industry exists in the deep-rooted contradictions and problems have not been effectively resolved, industrial development level and supervisory capacity and to protect public safety of drug use there is a certain the gap. "State Food and Drug Administration Wu Zhen, deputy director, said in a conference, present, China's pharmaceutical industry," many small, scattered, low "has not been fundamentally changed, the overall level is not high, irrational industrial structure, quality management level is not high, the system ability to innovate is not strong, these issues will certainly affect the pharmaceutical industry in China to further rapid development.
� 
The sector say that with the continuous expansion of the domestic market, China's pharmaceutical industry, low-level redundant construction has been the adverse impact of emerging trends. On the one hand, due to industry concentration is low, many scattered small-scale enterprises consumption and take up a lot of money, to a certain extent, the development of the industry squeezed space; the other hand, repeated construction led to excess capacity, competition, thereby drug quality and population medicine has security implications.
� 
At the same time, lack of innovative capacity to enable the sustainable development of the whole industry will be restricted. As product homogenization serious, technical value-added is low, domestic enterprises and multinational pharmaceutical companies in the long-term competition in the domestic market at a disadvantage, preparation products to global markets struggling, bulk drugs export structure is irrational, in particular, more use of traditional Chinese medicine extract low-value-added exports and low economic efficiency.
� � � 2, bear the brunt of industrial upgrading
� 
In this year's government work report, change the mode of economic development related to industrial restructuring, SME development, service development, and energy-efficient emission reduction and regional coordination development. With special emphasis on great efforts to cultivate a strategic new industries. This will undoubtedly change in mode of development for the pharmaceutical industry, pointed out the direction.
� 
Yu Ming believes that the pharmaceutical industry, changes in mode of development there are basically two directions, first, upgrading of traditional industries, and second, the rapid development of bio-pharmaceutical industry. "Promoting industrial upgrading, and improve production efficiency is the first to the core issue."
� 
One in the industry believe that the total U.S. population of 250 million, which is only 250 pharmaceutical companies. For the 1.3 billion population of China, 4700 a number of pharmaceutical companies too much. "Domestic pharmaceutical companies many small, scattered, chaotic situation has greatly restricted the development of the industry, industry concentration needs to be improved." Kang Pat Beijing Economic and Technical Research Center of Chinese Medicine, said Li Lei, director for the pharmaceutical industry, the state should be introduced to a comprehensive coordination of the industrial structure adjustment policies, through product registration and coordination of overcapacity, technological innovation and price policy coordination, level of development and sustainable use of resources, coordination, high pollution, high consumption and environmental protection, ecological balance, GMP, GSP stages of development and quality management coordinated, all-round promotion of industrial upgrading.
� � � � 3, the product transition, a key
� 
In the past in 2009, the central government invested 151.2 billion yuan of funds to accelerate the implementation of national science and technology major projects to try to reverse the tradition of scientific and technological innovation through the extensive mode of economic development, the real economic development pattern.
� 
Relevant industry sources have told reporters that last year a major national science and technology special "significant new drugs create" an input 6.6 billion yuan for national drug innovation system, in the "Shier Wu" and "Shi Sanwu" period, China's pharmaceutical R & D will have to look forward to a breakthrough.
� 
National attention and strong support from another level, shows that the transformation of our pharmaceutical products have started full speed. In the changing mode of economic development in the process of restructuring and industrial upgrading products go hand in hand, but also more critical.

Semoga artikel Changing mode of economic development of China's pharmaceutical industry will be bright prospect bermanfaat bagi Anda. Jika kamu suka dengan artikel Changing mode of economic development of China's pharmaceutical industry will be bright prospect ini, like dan bagikan ketemanmu.